Showing 1 - 10 of 2,845
decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain … intellectual property. Several firms in India and China are performing advanced R&D and are moving into the highest-value segments …
Persistent link: https://www.econbiz.de/10014047447
Persistent link: https://www.econbiz.de/10011717699
Persistent link: https://www.econbiz.de/10003985374
Persistent link: https://www.econbiz.de/10009752650
Persistent link: https://www.econbiz.de/10011453911
Persistent link: https://www.econbiz.de/10001480694
Persistent link: https://www.econbiz.de/10001294370
1. Pharmaceutical industry structure and its effect on marketing performance and product innovation -- 2. The environmental forces that influence industry stakeholders and shape their interactions -- 3. Global health care systems and market access : variations on a theme -- 4. The structure of...
Persistent link: https://www.econbiz.de/10013181948
Randomized Controlled Trials (RCT) data continues to be the gold standard as evident for clinical safety and efficacy. It supports product registration and prescriptions in pharma and healthcare. RCTs provide data in the real-world clinical settings; however, their controlled nature within the...
Persistent link: https://www.econbiz.de/10012981010
Frontmatter -- CONTENTS -- Acknowledgments -- The Pharmaceutical Nexus -- Globalizing Human Subjects Research -- The New Medical Oikumene -- Educating for Global Mental Health: The Adoption of SSRIs in Japan -- High Contact: Gifts and Surveillance in Argentina -- Addiction Markets: The Case of...
Persistent link: https://www.econbiz.de/10014488467